secwatch.observer — SEC 8-K summary
======================================

Issuer:     Frazier Life Sciences Acquisition Corp. II (FLSC)
CIK:        0002153598
Form:       8-K
Filed at:   2026-10-22T21:24:25+00:00
Accession:  0001193125-26-429129
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Frazier Life Sciences Acquisition Corp. II closes $75M IPO and $3M sponsor private placement
--------------------------------------------------------------------------------

- IPO of 7,500,000 Class A ordinary shares at $10.00 per share generated $75,000,000 gross proceeds; offering costs were $4,111,319.
- Sponsor Frazier Life Sciences Holdings II, LLC bought 300,000 Class A shares at $10.00 in a $3,000,000 private placement closed simultaneously with the IPO.
- $75,000,000 was deposited in a U.S. trust account with Continental Stock Transfer & Trust Company as trustee; cash outside the trust was $1,762,481.
- Balance sheet shows $3,000,000 deferred underwriting fee payable plus a $750,000 upfront underwriting discount; accumulated deficit of $1,226,690 as of October 15, 2026.
- Company has not selected a business combination target or held substantive talks; it has 24 months from the IPO close to consummate a deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2153598/000119312526429129/0001193125-26-429129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2153598/000119312526429129/d430914d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-429129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer